Where can I read JAZZ's latest 10-K?

JAZZ's latest annual report, a 10-K, was filed on Feb 24, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.

When did JAZZ last file an 8-K?

On Sep 23, 2026: material definitive agreement; new financial obligation. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Aug 3, 2026.

Are JAZZ insiders buying or selling?

Over the last 13 months insiders sold $46.0M in 22 sales and bought nothing on the open market; 74 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: Patil Neena M (EVP & Chief Legal Officer) sold 1,200 shares on Sep 10, 2026 for $289K, under a 10b5-1 plan. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.

How many SEC filings has JAZZ made?

2,164 filings are on EDGAR under the registrant records that have been Jazz Pharmaceuticals plc Common Stock (Ireland), going back to 2003; 1,371 of them are insider ownership forms (Forms 3, 4, 5 and 144).

Share this page

JAZZ

$235.67+1.14%

as of close, Oct 2, 2026

☾ AH $235.67 +1.14%

Jazz Pharmaceuticals plc Common Stock (Ireland)Stock · Health CareNasdaq Composite 0.03%US Stock Market 0.02%Russell 3000 0.02%

PeersMRNALLYUNHJNJMRKTMO

JAZZ SEC filings (2026)

CIK 1232524 · Pharmaceutical Preparations (SIC 2834) · incorporated in L2 · fiscal year ends in December

2,164 filings on EDGAR since 2003 · 37 annual, 59 quarterly, 275 current · financial statements · earnings

Latest 10-K

Feb 24, 2026

fiscal year to Dec 31, 2025

Latest 10-Q

Aug 3, 2026

quarter to Jun 30, 2026

Latest 8-K

Sep 23, 2026

Material definitive agreement; New financial obligation

Last earnings release

Aug 3, 2026

$4.89 vs $5.06 · ▲ 4.0%

Filings on file

2,164

since 2003, 1,371 insider forms

What happened, last 12 months#

Every earnings release with its print, every report with its quarter, the other 8-Ks by what they covered, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.

Insider transactions#

What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.

Over the last 13 months insiders sold $46.0M in 22 sales and bought nothing on the open market; 74 other transactions (awards, exercises, tax withholding, gifts and plan purchases).

Date	Insider	Action	Shares	Price	Value	Held after	Filing
Sep 10, 2026Form 4	Patil Neena MEVP & Chief Legal OfficerSold · $289K · 1,200 sh · 10b5-1	Sold· 10b5-1 plan	1,200	$240.94	$289K	47,671	Form 4
Sep 8, 2026Form 4	GALA RENEE DPresident & CEOSold · $486K · 2,000 sh · 10b5-1	Sold· 10b5-1 plan	2,000	$243.03	$486K	143,394	Form 4
Sep 1, 2026Form 4	COZADD BRUCE CDirectorSold · $1.5M · 6,000 sh · 10b5-1	Sold· 10b5-1 plan	6,000	$250.13	$1.5M	351,875	Form 4
Aug 27, 2026Form 4	Iannone RobertEVP, Global Head of R&D & CMOSold · $19.2M · 76,921 sh · 10b5-1	Sold· 10b5-1 plan	76,921	$247.86–$252.76	$19.2M	65,686	Form 4
Aug 3, 2026Form 4	COZADD BRUCE CDirectorSold · $1.5M · 6,000 sh · 10b5-1	Sold· 10b5-1 plan	6,000	$252.98	$1.5M	360,682	Form 4
Jul 1, 2026Form 4	COZADD BRUCE CDirectorSold · $1.4M · 6,000 sh · 10b5-1	Sold· 10b5-1 plan	6,000	$240.47	$1.4M	366,682	Form 4
Jun 15, 2026Form 4	Smith Mark DouglasDirectorSold · $267K · 1,157 sh · 10b5-1	Sold· 10b5-1 plan	1,157	$230.55	$267K	9,680	Form 4
Jun 10, 2026Form 4	Patil Neena MEVP & Chief Legal OfficerSold · $278K · 1,200 sh · 10b5-1	Sold· 10b5-1 plan	1,200	$231.83	$278K	51,549	Form 4
Jun 1, 2026Form 4	COZADD BRUCE CDirectorSold · $1.4M · 6,000 sh · 10b5-1	Sold· 10b5-1 plan	6,000	$235.12	$1.4M	372,682	Form 4
May 28, 2026Form 4	Pearce SamanthaEVP, Chief Commercial OfficerSold · $1.6M · 6,907 sh	Sold	6,907	$235.41	$1.6M	50,272	Form 4
May 28, 2026Form 4	Patil Neena MEVP & Chief Legal OfficerSold · $282K · 1,192 sh · 10b5-1	Sold· 10b5-1 plan	1,192	$236.97	$282K	52,626	Form 4
May 22, 2026Form 4	Winningham Rick EDirectorSold · $662K · 2,741 sh	Sold	2,741	$241.57	$662K	9,567	Form 4
May 22, 2026Form 4	McSharry Heather AnnDirectorSold · $482K · 2,000 sh	Sold	2,000	$241.00	$482K	18,449	Form 4
May 1, 2026Form 4	COZADD BRUCE CDirectorSold · $1.2M · 6,000 sh · 10b5-1	Sold· 10b5-1 plan	6,000	$203.33	$1.2M	378,682	Form 4
Apr 1, 2026Form 4	COZADD BRUCE CDirectorSold · $1.1M · 6,000 sh · 10b5-1	Sold· 10b5-1 plan	6,000	$190.22–$191.74	$1.1M	384,682	Form 4
Mar 9, 2026Form 4	Carr PatriciaSVP, Chief Accounting OfficerSold · $235K · 1,287 sh	Sold	1,287	$182.94	$235K	6,512	Form 4
Mar 3, 2026Form 4	COZADD BRUCE CDirectorSold · $1.1M · 6,000 sh · 10b5-1	Sold· 10b5-1 plan	6,000	$186.09–$187.84	$1.1M	405,796	Form 4
Feb 27, 2026Form 4	RIEDEL NORBERT GDirectorSold · $656K · 3,415 sh	Sold	3,415	$192.00	$656K	7,024	Form 4
Feb 27, 2026Form 4	Carr PatriciaSVP, Chief Accounting OfficerSold · $213K · 1,117 sh	Sold	1,117	$190.91	$213K	9,235	Form 4
Feb 26, 2026Form 4	Patil Neena MEVP & Chief Legal OfficerSold · $10.7M · 55,600 sh	Sold	55,600	$189.81–$193.60	$10.7M	58,818	Form 4
Feb 26, 2026Form 4	Henderson Mary ElizabethSVP, Technical OperationsSold · $1.0M · 5,343 sh	Sold	5,343	$194.49	$1.0M	28,728	Form 4
Feb 26, 2026Form 4	Carr PatriciaSVP, Chief Accounting OfficerSold · $243K · 1,253 sh	Sold	1,253	$194.11	$243K	10,352	Form 4

Awards, exercises, withholding and plan purchases · 74 transactions

Date	Insider	Action	Shares	Price	Value	Held after	Filing
Sep 8, 2026Form 4	GALA RENEE DPresident & CEOTax withholding · $485K · 1,967 sh · 10b5-1	Tax withholding· 10b5-1 plan	1,967	$246.81	$485K	145,394	Form 4
Sep 8, 2026Form 4	Henderson Mary ElizabethSVP, Technical OperationsTax withholding · $347K · 1,427 sh	Tax withholding	1,427	$241.20–$243.03	$347K	23,815	Form 4
Aug 31, 2026Form 4	Henderson Mary ElizabethSVP, Technical OperationsTax withholding · $505K · 2,092 sh	Tax withholding	2,092	$241.39–$244.64	$505K	25,242	Form 4
Aug 31, 2026Form 4	McSharry Heather AnnDirectorTax withholding · $448K · 1,855 sh	Tax withholding	1,855	$241.39–$244.64	$448K	18,199	Form 4
Aug 31, 2026Form 4	Kennedy PatrickDirectorTax withholding · $448K · 1,855 sh	Tax withholding	1,855	$241.39–$244.06	$448K	6,452	Form 4
Aug 31, 2026Form 4	RIEDEL NORBERT GDirectorTax withholding · $412K · 1,706 sh	Tax withholding	1,706	$241.39–$244.64	$412K	6,923	Form 4
Aug 31, 2026Form 4	ENRIGHT PATRICK GDirectorTax withholding · $412K · 1,706 sh	Tax withholding	1,706	$241.39–$244.64	$412K	21,278	Form 4
Aug 31, 2026Form 4	Winningham Rick EDirectorTax withholding · $412K · 1,706 sh	Tax withholding	1,706	$241.39–$244.64	$412K	9,466	Form 4
Aug 31, 2026Form 4	Smith Mark DouglasDirectorTax withholding · $412K · 1,706 sh	Tax withholding	1,706	$241.39–$244.64	$412K	9,579	Form 4
Aug 31, 2026Form 4	Hamill LauraDirectorTax withholding · $412K · 1,706 sh	Tax withholding	1,706	$241.39–$244.06	$412K	6,832	Form 4
Aug 31, 2026Form 4	Cook Jennifer E.DirectorTax withholding · $412K · 1,706 sh	Tax withholding	1,706	$241.39–$244.06	$412K	10,736	Form 4
Aug 31, 2026Form 4	COZADD BRUCE CDirectorTax withholding · $294K · 1,219 sh · 10b5-1	Tax withholding· 10b5-1 plan	1,219	$241.39–$244.06	$294K	357,875	Form 4
Aug 31, 2026Form 4	LOVE TED WDirectorTax withholding · $179K · 743 sh	Tax withholding	743	$241.39–$244.06	$179K	2,389	Form 4
Aug 27, 2026Form 4	Iannone RobertEVP, Global Head of R&D & CMOExercise or conversion · $7.2M · 57,500 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	57,500	$113.10–$137.12	$7.2M	142,607	Form 4
Aug 27, 2026Form 4	Iannone RobertEVP, Global Head of R&D & CMOExercise or conversion · Non-Qualified Stock Option… · $0 · 53,700 sh · 10b5-1	Exercise or conversion· Non-Qualified Stock Option…· 10b5-1 plan	53,700	$0.00	$0	0	Form 4
Aug 27, 2026Form 4	Iannone RobertEVP, Global Head of R&D & CMOExercise or conversion · Incentive Stock Option (ri… · $0 · 3,800 sh · 10b5-1	Exercise or conversion· Incentive Stock Option (ri…· 10b5-1 plan	3,800	$0.00	$0	0	Form 4
Aug 5, 2026Form 4	Pearce SamanthaEVP, Chief Commercial OfficerTax withholding · $204K · 780 sh	Tax withholding	780	$261.62	$204K	47,131	Form 4
Aug 5, 2026Form 4	RIEDEL NORBERT GDirectorAward · $0 · 1,605 sh	Award	1,605	$0.00	$0	8,629	Form 4
Aug 5, 2026Form 4	LOVE TED WDirectorAward · $0 · 1,605 sh	Award	1,605	$0.00	$0	3,132	Form 4
Aug 5, 2026Form 4	COZADD BRUCE CDirectorAward · $0 · 1,605 sh	Award	1,605	$0.00	$0	362,287	Form 4
Aug 5, 2026Form 4	ENRIGHT PATRICK GDirectorAward · $0 · 1,605 sh	Award	1,605	$0.00	$0	22,984	Form 4
Aug 5, 2026Form 4	Winningham Rick EDirectorAward · $0 · 1,605 sh	Award	1,605	$0.00	$0	11,172	Form 4
Aug 5, 2026Form 4	Mulligan SeamusDirectorAward · $0 · 1,605 sh	Award	1,605	$0.00	$0	1,184,633	Form 4
Aug 5, 2026Form 4	McSharry Heather AnnDirectorAward · $0 · 1,605 sh	Award	1,605	$0.00	$0	20,054	Form 4
Aug 5, 2026Form 4	Hamill LauraDirectorAward · $0 · 1,605 sh	Award	1,605	$0.00	$0	8,538	Form 4
Aug 5, 2026Form 4	Cook Jennifer E.DirectorAward · $0 · 1,605 sh	Award	1,605	$0.00	$0	12,442	Form 4
Aug 5, 2026Form 4	Smith Mark DouglasDirectorAward · $0 · 1,605 sh	Award	1,605	$0.00	$0	11,285	Form 4
Aug 5, 2026Form 4	Kennedy PatrickDirectorAward · $0 · 1,605 sh	Award	1,605	$0.00	$0	8,307	Form 4
Jun 30, 2026Form 4	GALA RENEE DPresident & CEOTax withholding · $1.1M · 4,835 sh	Tax withholding	4,835	$237.72	$1.1M	147,361	Form 4
Jun 30, 2026Form 4	Iannone RobertEVP, Global Head of R&D & CMOTax withholding · $895K · 3,764 sh	Tax withholding	3,764	$237.72	$895K	85,107	Form 4
Jun 30, 2026Form 4	Johnson Philip LEVP & Chief Financial OfficerTax withholding · $795K · 3,343 sh	Tax withholding	3,343	$237.72	$795K	56,431	Form 4
Jun 30, 2026Form 4	Patil Neena MEVP & Chief Legal OfficerTax withholding · $637K · 2,678 sh	Tax withholding	2,678	$237.72	$637K	48,871	Form 4
Jun 30, 2026Form 4	Pearce SamanthaEVP, Chief Commercial OfficerTax withholding · $601K · 2,527 sh	Tax withholding	2,527	$237.72	$601K	47,911	Form 4
Jun 3, 2026Form 4	GALA RENEE DPresident & CEOGift · $0 · 600 sh	Gift	600	$0.00	$0	152,196	Form 4
May 28, 2026Form 4	Pearce SamanthaEVP, Chief Commercial OfficerExercise or conversion · $756K · 6,907 sh	Exercise or conversion	6,907	$109.45	$756K	57,179	Form 4
May 28, 2026Form 4	Mulligan SeamusDirectorExercise or conversion · $472K · 3,415 sh	Exercise or conversion	3,415	$138.08	$472K	1,183,028	Form 4
May 28, 2026Form 4	Pearce SamanthaEVP, Chief Commercial OfficerExercise or conversion · Non-Qualified Stock Option… · $0 · 6,907 sh	Exercise or conversion· Non-Qualified Stock Option…	6,907	$0.00	$0	0	Form 4
May 28, 2026Form 4	Mulligan SeamusDirectorExercise or conversion · Non-Qualified Stock Option… · $0 · 3,415 sh	Exercise or conversion· Non-Qualified Stock Option…	3,415	$0.00	$0	0	Form 4
May 22, 2026Form 4	Winningham Rick EDirectorExercise or conversion · $472K · 3,415 sh	Exercise or conversion	3,415	$138.08	$472K	12,308	Form 4
May 22, 2026Form 4	Winningham Rick EDirectorExercise or conversion · Non-Qualified Stock Option… · $0 · 3,415 sh	Exercise or conversion· Non-Qualified Stock Option…	3,415	$0.00	$0	0	Form 4
Mar 5, 2026Form 4	COZADD BRUCE CDirectorTax withholding · $2.9M · 15,114 sh	Tax withholding	15,114	$188.69	$2.9M	390,682	Form 4
Mar 5, 2026Form 4	GALA RENEE DPresident & CEOTax withholding · $1.3M · 7,065 sh	Tax withholding	7,065	$188.69	$1.3M	152,630	Form 4
Mar 5, 2026Form 4	Iannone RobertEVP, Global Head of R&D & CMOTax withholding · $1.2M · 6,209 sh	Tax withholding	6,209	$188.69	$1.2M	88,871	Form 4
Mar 5, 2026Form 4	Patil Neena MEVP & Chief Legal OfficerTax withholding · $943K · 5,000 sh	Tax withholding	5,000	$188.69	$943K	53,818	Form 4
Mar 5, 2026Form 4	Johnson Philip LEVP & Chief Financial OfficerTax withholding · $493K · 2,615 sh	Tax withholding	2,615	$188.69	$493K	59,608	Form 4
Mar 5, 2026Form 4	Pearce SamanthaEVP, Chief Commercial OfficerTax withholding · $472K · 2,503 sh	Tax withholding	2,503	$188.69	$472K	50,272	Form 4
Mar 5, 2026Form 4	Carr PatriciaSVP, Chief Accounting OfficerTax withholding · $268K · 1,436 sh	Tax withholding	1,436	$186.77	$268K	7,799	Form 4
Mar 5, 2026Form 4	Henderson Mary ElizabethSVP, Technical OperationsTax withholding · $260K · 1,394 sh	Tax withholding	1,394	$186.75	$260K	27,334	Form 4
Feb 27, 2026Form 4	RIEDEL NORBERT GDirectorExercise or conversion · $472K · 3,415 sh	Exercise or conversion	3,415	$138.08	$472K	10,439	Form 4
Feb 27, 2026Form 4	RIEDEL NORBERT GDirectorExercise or conversion · Non-Qualified Stock Option… · $0 · 3,415 sh	Exercise or conversion· Non-Qualified Stock Option…	3,415	$0.00	$0	0	Form 4
Feb 26, 2026Form 4	Patil Neena MEVP & Chief Legal OfficerExercise or conversion · $6.5M · 51,000 sh	Exercise or conversion	51,000	$113.10–$137.12	$6.5M	71,307	Form 4
Feb 26, 2026Form 4	Patil Neena MEVP & Chief Legal OfficerExercise or conversion · Non-Qualified Stock Option… · $0 · 47,209 sh	Exercise or conversion· Non-Qualified Stock Option…	47,209	$0.00	$0	0	Form 4
Feb 26, 2026Form 4	GALA RENEE DPresident & CEOAward · $0 · 44,465 sh	Award	44,465	$0.00	$0	159,695	Form 4
Feb 26, 2026Form 4	Iannone RobertEVP, Global Head of R&D & CMOAward · $0 · 14,822 sh	Award	14,822	$0.00	$0	95,080	Form 4
Feb 26, 2026Form 4	Johnson Philip LEVP & Chief Financial OfficerAward · $0 · 11,857 sh	Award	11,857	$0.00	$0	62,223	Form 4
Feb 26, 2026Form 4	Patil Neena MEVP & Chief Legal OfficerAward · $0 · 10,079 sh	Award	10,079	$0.00	$0	78,470	Form 4
Feb 26, 2026Form 4	Pearce SamanthaEVP, Chief Commercial OfficerAward · $0 · 9,782 sh	Award	9,782	$0.00	$0	52,775	Form 4
Feb 26, 2026Form 4	Henderson Mary ElizabethSVP, Technical OperationsAward · $0 · 4,447 sh	Award	4,447	$0.00	$0	34,071	Form 4
Feb 26, 2026Form 4	Patil Neena MEVP & Chief Legal OfficerExercise or conversion · Incentive Stock Option (ri… · $0 · 3,791 sh	Exercise or conversion· Incentive Stock Option (ri…	3,791	$0.00	$0	0	Form 4
Feb 26, 2026Form 4	Carr PatriciaSVP, Chief Accounting OfficerAward · $0 · 2,223 sh	Award	2,223	$0.00	$0	11,605	Form 4
Feb 26, 2026Form 4	LOVE TED WDirectorAward · $0 · 1,527 sh	Award	1,527	$0.00	$0	1,527	Form 4
Jan 16, 2026Form 4	COZADD BRUCE CDirectorTax withholding · $3.0M · 17,453 sh	Tax withholding	17,453	$171.16	$3.0M	411,796	Form 4
Jan 16, 2026Form 4	GALA RENEE DPresident & CEOTax withholding · $919K · 5,371 sh	Tax withholding	5,371	$171.16	$919K	115,230	Form 4
Jan 16, 2026Form 4	Iannone RobertEVP, Global Head of R&D & CMOTax withholding · $709K · 4,140 sh	Tax withholding	4,140	$171.16	$709K	80,258	Form 4
Jan 16, 2026Form 4	Patil Neena MEVP & Chief Legal OfficerOther · $561K · 3,275 sh	Other	3,275	$171.16	$561K	53,339	Form 4
Jan 16, 2026Form 4	Pearce SamanthaEVP, Chief Commercial OfficerTax withholding · $274K · 1,599 sh	Tax withholding	1,599	$171.16	$274K	42,993	Form 4
Jan 16, 2026Form 4	COZADD BRUCE CDirectorAward · $0 · 35,917 sh	Award	35,917	$0.00	$0	429,249	Form 4
Jan 16, 2026Form 4	GALA RENEE DPresident & CEOAward · $0 · 12,741 sh	Award	12,741	$0.00	$0	120,601	Form 4
Jan 16, 2026Form 4	Iannone RobertEVP, Global Head of R&D & CMOAward · $0 · 11,699 sh	Award	11,699	$0.00	$0	84,398	Form 4
Jan 16, 2026Form 4	Henderson Mary ElizabethSVP, Technical OperationsAward · $0 · 10,116 sh	Award	10,116	$0.00	$0	29,624	Form 4
Jan 16, 2026Form 4	Patil Neena MEVP & Chief Legal OfficerAward · $0 · 8,852 sh	Award	8,852	$0.00	$0	56,614	Form 4
Jan 16, 2026Form 4	Pearce SamanthaEVP, Chief Commercial OfficerAward · $0 · 3,637 sh	Award	3,637	$0.00	$0	44,592	Form 4
Jan 16, 2026Form 4	Carr PatriciaSVP, Chief Accounting OfficerAward · $0 · 2,370 sh	Award	2,370	$0.00	$0	9,382	Form 4
Aug 18, 2025Form 4	ENRIGHT PATRICK GDirectorOther · $0 · 5,000 sh	Other	5,000	$0.00	$0	21,379	Form 4

Reports and proxy statements#

Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K is described by its items. A form opens the document on EDGAR, or the filing’s index where it furnishes exhibits (an earnings release is the 8-K’s Exhibit 99.1).

2026 · 21 filings

Filed	Form	What it is	Period
Sep 23, 20268-K	8-K	Material definitive agreement; New financial obligation	Sep 23, 2026
Sep 15, 20268-K	8-K	Regulation FD disclosure	Sep 15, 2026
Aug 31, 20268-K	8-K	Material definitive agreement; New financial obligation; Unregistered sale of equity; Other events	Aug 26, 2026
Aug 25, 20268-K	8-K	Other events	Aug 25, 2026
Aug 10, 20268-K	8-K	Material definitive agreement	Aug 10, 2026
Aug 10, 20268-K	8-K	Regulation FD disclosure	Aug 10, 2026
Aug 3, 202610-Q	10-Q	Quarterly report, Q2 2026 — revenue $1.21B (+16% y/y), net income $192.8M, EPS $2.78	Jun 30, 2026
Aug 3, 20268-K	8-K	Earnings release — EPS $4.89 vs $5.06 est. (−3.4%); revenue $1.21B (+16% y/y) 4.0%	Aug 3, 2026
Jul 24, 20268-K	8-K	Shareholder vote results	Jul 23, 2026
Jul 14, 2026DEFA14A	DEFA14A	Additional proxy materials	—
Jun 8, 2026ARS	ARS	Annual report to shareholders	Dec 31, 2025
Jun 8, 2026DEFA14A	DEFA14A	Additional proxy materials	—
Jun 8, 2026DEF 14A	DEF 14A	Proxy statement	Jul 23, 2026
May 29, 2026PRE 14A	PRE 14A	Preliminary proxy statement	Jul 23, 2026
May 29, 20268-K	8-K	Directors or officers; compensation	May 25, 2026
May 5, 202610-Q	10-Q	Quarterly report, Q1 2026 — revenue $1.07B (+19% y/y), net income $293.1M, EPS $4.43	Mar 31, 2026
May 5, 20268-K	8-K	Earnings release — EPS $5.46 vs $3.82 est. (+42.9%); revenue $1.07B (+19% y/y) 7.7%	May 5, 2026
Apr 24, 202610-K/A	10-K/A	Annual report, amended	Dec 31, 2025
Feb 24, 202610-K	10-K	Annual report, FY2025 — revenue $4.27B (+5% y/y), net income −$356.1M, EPS −$5.84	Dec 31, 2025
Feb 24, 20268-K	8-K	Earnings release — EPS $5.76 vs $5.65 est. (+1.9%); revenue $1.20B (+10% y/y) 13.2%	Feb 24, 2026
Jan 12, 20268-K	8-K	Results of operations	Jan 12, 2026

2025 · 25 filings

Filed	Form	What it is	Period
Nov 17, 20258-K	8-K	Other events	Nov 17, 2025
Nov 5, 202510-Q	10-Q	Quarterly report, Q3 2025 — revenue $1.13B (+7% y/y), net income $251.4M, EPS $4.08	Sep 30, 2025
Nov 5, 20258-K	8-K	Earnings release — EPS $6.99 vs $4.80 est. (+45.6%); revenue $1.13B (+7% y/y) 2.3%	Nov 5, 2025
Oct 28, 20258-K	8-K	Directors or officers; compensation	Oct 23, 2025
Oct 22, 20258-K	8-K	Other events	Oct 21, 2025
Aug 6, 202510-Q	10-Q	Quarterly report, Q2 2025 — revenue $1.05B (+2% y/y), net income −$718.5M, EPS −$11.74	Jun 30, 2025
Aug 5, 20258-K	8-K	Results of operations	Aug 5, 2025
Jul 25, 20258-K	8-K	Shareholder vote results	Jul 24, 2025
Jul 14, 2025DEFA14A	DEFA14A	Additional proxy materials	—
Jul 10, 2025DEFA14A	DEFA14A	Additional proxy materials	—
Jul 10, 20258-K	8-K	Directors or officers; compensation; Regulation FD disclosure	Jul 8, 2025
Jun 6, 2025ARS	ARS	Annual report to shareholders	Dec 31, 2024
Jun 6, 2025DEFA14A	DEFA14A	Additional proxy materials	—
Jun 6, 2025DEF 14A	DEF 14A	Proxy statement	Jul 24, 2025
May 23, 2025PRE 14A	PRE 14A	Preliminary proxy statement	Jul 24, 2025
May 7, 202510-Q	10-Q	Quarterly report, Q1 2025 — revenue $897.8M (−0% y/y), net income −$92.5M, EPS −$1.52	Mar 31, 2025
May 6, 20258-K	8-K	Results of operations	May 6, 2025
Apr 25, 202510-K/A	10-K/A	Annual report, amended	Dec 31, 2024
Apr 21, 20258-K	8-K	Regulation FD disclosure; Other events	Apr 21, 2025
Apr 8, 20258-K	8-K	Material definitive agreement	Apr 7, 2025
Mar 5, 20258-K/A	8-K/A	Material definitive agreement; Regulation FD disclosure	Mar 4, 2025
Mar 5, 20258-K	8-K	Material definitive agreement; Regulation FD disclosure	Mar 4, 2025
Feb 26, 202510-K	10-K	Annual report, FY2024 — revenue $4.07B (+6% y/y), net income $560.1M, EPS $8.65	Dec 31, 2024
Feb 25, 20258-K	8-K	Results of operations	Feb 25, 2025
Jan 13, 20258-K	8-K	Results of operations	Jan 13, 2025

2024 · 27 filings

Filed	Form	What it is	Period
Dec 16, 20248-K	8-K	Directors or officers; compensation	Dec 11, 2024
Nov 26, 20248-K	8-K	Material definitive agreement; New financial obligation	Nov 26, 2024
Nov 21, 20248-K	8-K	Other events	Nov 20, 2024
Nov 7, 202410-Q	10-Q	Quarterly report, Q3 2024 — revenue $1.05B (+9% y/y), net income $215.1M, EPS $3.42	Sep 30, 2024
Nov 6, 20248-K	8-K	Results of operations	Nov 6, 2024
Oct 16, 20248-K	8-K	Termination of a material agreement	Oct 10, 2024
Sep 6, 20248-K	8-K	Material definitive agreement; New financial obligation; Unregistered sale of equity; Other events	Sep 3, 2024
Aug 28, 20248-K	8-K	Other events	Aug 27, 2024
Aug 1, 202410-Q	10-Q	Quarterly report, Q2 2024 — revenue $1.02B (+7% y/y), net income $168.6M, EPS $2.49	Jun 30, 2024
Jul 31, 20248-K	8-K	Results of operations	Jul 31, 2024
Jul 26, 20248-K	8-K	Shareholder vote results	Jul 25, 2024
Jul 22, 2024DEFA14A	DEFA14A	Additional proxy materials	—
Jul 22, 20248-K	8-K	Material definitive agreement; New financial obligation	Jul 19, 2024
Jun 14, 2024ARS	ARS	Annual report to shareholders	Dec 31, 2023
Jun 14, 2024DEFA14A	DEFA14A	Additional proxy materials	—
Jun 14, 2024DEF 14A	DEF 14A	Proxy statement	Jul 25, 2024
Jun 3, 2024PRE 14A	PRE 14A	Preliminary proxy statement	Jul 25, 2024
May 31, 20248-K	8-K	Directors or officers; compensation	May 31, 2024
May 2, 202410-Q	10-Q	Quarterly report, Q1 2024 — revenue $902.0M (+1% y/y), net income −$14.6M, EPS −$0.23	Mar 31, 2024
May 1, 20248-K	8-K	Results of operations	May 1, 2024
Apr 26, 202410-K/A	10-K/A	Annual report, amended	Dec 31, 2023
Feb 28, 202410-K	10-K	Annual report, FY2023 — revenue $3.83B (+5% y/y), net income $414.8M, EPS $6.10	Dec 31, 2023
Feb 28, 20248-K	8-K	Results of operations	Feb 28, 2024
Feb 27, 20248-K	8-K	Directors or officers; compensation	Feb 23, 2024
Feb 21, 20248-K	8-K	Directors or officers; compensation; Regulation FD disclosure	Feb 21, 2024
Jan 25, 20248-K	8-K	Material definitive agreement; New financial obligation	Jan 19, 2024
Jan 8, 20248-K	8-K	Results of operations	Jan 8, 2024

2023 · 19 filings — 9 × 8-K, 3 × 10-Q, 2 × DEFA14A and 5 other forms

Filed	Form	What it is	Period
Nov 8, 202310-Q	10-Q	Quarterly report, Q3 2023 — revenue $972.1M (+3% y/y), net income $146.8M, EPS $2.14	Sep 30, 2023
Aug 9, 202310-Q	10-Q	Quarterly report, Q2 2023 — revenue $957.3M (+3% y/y), net income $104.4M, EPS $1.52	Jun 30, 2023
Jul 26, 2023DEFA14A	DEFA14A	Additional proxy materials	—
Jun 16, 2023ARS	ARS	Annual report to shareholders	Dec 31, 2022
Jun 16, 2023DEFA14A	DEFA14A	Additional proxy materials	—
Jun 16, 2023DEF 14A	DEF 14A	Proxy statement	—
Jun 6, 2023PRE 14A	PRE 14A	Preliminary proxy statement	—
May 10, 202310-Q	10-Q	Quarterly report, Q1 2023 — revenue $892.8M (+10% y/y), net income $69.4M, EPS $1.04	Mar 31, 2023
May 1, 202310-K/A	10-K/A	Annual report, amended	Dec 31, 2022
Mar 1, 202310-K	10-K	Annual report, FY2022 — revenue $3.66B (+18% y/y), net income −$224.1M, EPS −$3.58	Dec 31, 2022

9 current reports (8-K) not listed; the year is on EDGAR.

2022 · 24 filings — 12 × 8-K, 5 × DEFA14A, 3 × 10-Q and 4 other forms

Filed	Form	What it is	Period
Nov 9, 202210-Q	10-Q	Quarterly report, Q3 2022 — revenue $940.7M (+12% y/y), net income −$19.6M, EPS −$0.31	Sep 30, 2022
Aug 3, 202210-Q	10-Q	Quarterly report, Q2 2022 — revenue $932.9M (+24% y/y), net income $34.7M, EPS $0.55	Jun 30, 2022
Jul 22, 2022DEFA14A	DEFA14A	Additional proxy materials	—
Jul 15, 2022DEFA14A	DEFA14A	Additional proxy materials	—
Jul 7, 2022DEFA14A	DEFA14A	Additional proxy materials	—
Jun 17, 2022DEFA14A	DEFA14A	Additional proxy materials	—
Jun 13, 2022DEFA14A	DEFA14A	Additional proxy materials	—
Jun 13, 2022DEF 14A	DEF 14A	Proxy statement	Jul 28, 2022
May 31, 2022PRE 14A	PRE 14A	Preliminary proxy statement	Jul 28, 2022
May 4, 202210-Q	10-Q	Quarterly report, Q1 2022 — revenue $813.7M (+34% y/y), net income $1.6M, EPS $0.03	Mar 31, 2022
May 2, 202210-K/A	10-K/A	Annual report, amended	Dec 31, 2021
Mar 1, 202210-K	10-K	Annual report, FY2021 — revenue $3.09B (+31% y/y), net income −$329.7M, EPS −$5.52	Dec 31, 2021

12 current reports (8-K) not listed; the year is on EDGAR.

2021 · 47 filings — 17 × 8-K, 15 × DFAN14A, 5 × DEFA14A and 6 other forms

Filed	Form	What it is	Period
Nov 9, 202110-Q	10-Q	Quarterly report, Q3 2021 — revenue $838.1M (+39% y/y), net income −$52.8M, EPS −$0.86	Sep 30, 2021
Aug 30, 2021DEF 14A	DEF 14A	Proxy statement	Sep 23, 2021
Aug 19, 2021PRE 14A	PRE 14A	Preliminary proxy statement	Sep 23, 2021
Aug 3, 202110-Q	10-Q	Quarterly report, Q2 2021 — revenue $751.8M (+34% y/y), net income −$363.3M, EPS −$6.11	Jun 30, 2021
Jul 26, 2021DEFA14A	DEFA14A	Additional proxy materials	—
Jul 15, 2021DEFA14A	DEFA14A	Additional proxy materials	—
Jul 14, 2021DEFA14A	DEFA14A	Additional proxy materials	—
Jul 14, 2021DEFA14A	DEFA14A	Additional proxy materials	—
Jun 11, 2021DEFA14A	DEFA14A	Additional proxy materials	—
Jun 11, 2021DEF 14A	DEF 14A	Proxy statement	Jul 29, 2021
Jun 1, 2021PRE 14A	PRE 14A	Preliminary proxy statement	Jul 29, 2021
May 4, 202110-Q	10-Q	Quarterly report, Q1 2021 — revenue $607.6M (+14% y/y), net income $121.8M, EPS $2.09	Mar 31, 2021
Apr 23, 202110-K/A	10-K/A	Annual report, amended	Dec 31, 2020
Apr 20, 2021DFAN14A	DFAN14A	Proxy statements	—
Mar 23, 2021DFAN14A	DFAN14A	Proxy statements	—
Feb 26, 2021DFAN14A	DFAN14A	Proxy statements	—
Feb 24, 2021DFAN14A	DFAN14A	Proxy statements	—
Feb 24, 2021DFAN14A	DFAN14A	Proxy statements	—
Feb 24, 2021DFAN14A	DFAN14A	Proxy statements	—
Feb 23, 202110-K	10-K	Annual report, FY2020 — revenue $2.36B (+9% y/y), net income $238.6M, EPS $4.22	Dec 31, 2020
Feb 23, 2021DFAN14A	DFAN14A	Proxy statements	—
Feb 9, 2021DFAN14A	DFAN14A	Proxy statements	—
Feb 8, 2021DFAN14A	DFAN14A	Proxy statements	—
Feb 5, 2021DFAN14A	DFAN14A	Proxy statements	—
Feb 4, 2021DFAN14A	DFAN14A	Proxy statements	—
Feb 4, 2021DFAN14A	DFAN14A	Proxy statements	—
Feb 4, 2021DFAN14A	DFAN14A	Proxy statements	—
Feb 4, 2021DFAN14A	DFAN14A	Proxy statements	—
Feb 3, 2021DFAN14A	DFAN14A	Proxy statements	—

18 current reports (8-K) not listed; the year is on EDGAR.

2020 · 20 filings — 10 × 8-K, 3 × 10-Q, 3 × DEFA14A and 4 other forms

Filed	Form	What it is	Period
Nov 2, 202010-Q	10-Q	Quarterly report, Q3 2020 — revenue $600.9M (+12% y/y), net income $148.2M, EPS $2.64	Sep 30, 2020
Aug 4, 202010-Q	10-Q	Quarterly report, Q2 2020 — revenue $562.4M (+5% y/y), net income $114.8M, EPS $2.06	Jun 30, 2020
Jul 22, 2020DEFA14A	DEFA14A	Additional proxy materials	—
Jul 21, 2020DEFA14A	DEFA14A	Additional proxy materials	—
Jun 12, 2020DEFA14A	DEFA14A	Additional proxy materials	—
Jun 12, 2020DEF 14A	DEF 14A	Proxy statement	Jul 30, 2020
Jun 2, 2020PRE 14A	PRE 14A	Preliminary proxy statement	Jul 30, 2020
May 5, 202010-Q	10-Q	Quarterly report, Q1 2020 — revenue $534.7M (+5% y/y), net income −$157.8M, EPS −$2.82	Mar 31, 2020
Apr 24, 202010-K/A	10-K/A	Annual report, amended	Dec 31, 2019
Feb 25, 202010-K	10-K	Annual report, FY2019 — revenue $2.16B (+14% y/y), net income $523.4M, EPS $9.09	Dec 31, 2019

10 current reports (8-K) not listed; the year is on EDGAR.

2019 · 19 filings — 11 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms

Filed	Form	What it is	Period
Nov 5, 201910-Q	10-Q	Quarterly report, Q3 2019 — revenue $537.7M (+15% y/y), net income $102.3M, EPS $1.78	Sep 30, 2019
Aug 6, 201910-Q	10-Q	Quarterly report, Q2 2019 — revenue $534.1M (+7% y/y), net income $261.9M, EPS $4.56	Jun 30, 2019
Jun 14, 2019DEFA14A	DEFA14A	Additional proxy materials	—
Jun 14, 2019DEFA14A	DEFA14A	Additional proxy materials	—
Jun 14, 2019DEF 14A	DEF 14A	Proxy statement	Aug 1, 2019
May 7, 201910-Q	10-Q	Quarterly report, Q1 2019 — revenue $508.2M (+14% y/y), net income $85.2M, EPS $1.47	Mar 31, 2019
Apr 26, 201910-K/A	10-K/A	Annual report, amended	Dec 31, 2018
Feb 26, 201910-K	10-K	Annual report, FY2018 — revenue $1.89B (+17% y/y), net income $447.1M, EPS $7.30	Dec 31, 2018

11 current reports (8-K) not listed; the year is on EDGAR.

2018 · 18 filings — 10 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms

Filed	Form	What it is	Period
Nov 6, 201810-Q	10-Q	Quarterly report, Q3 2018 — revenue $469.4M (+14% y/y), net income $149.3M, EPS $2.41	Sep 30, 2018
Aug 7, 201810-Q	10-Q	Quarterly report, Q2 2018 — revenue $500.5M (+27% y/y), net income $92.3M, EPS $1.50	Jun 30, 2018
Jun 15, 2018DEFA14A	DEFA14A	Additional proxy materials	—
Jun 15, 2018DEFA14A	DEFA14A	Additional proxy materials	—
Jun 15, 2018DEF 14A	DEF 14A	Proxy statement	Aug 2, 2018
May 8, 201810-Q	10-Q	Quarterly report, Q1 2018 — revenue $444.6M (+18% y/y), net income $46.0M, EPS $0.75	Mar 31, 2018
Apr 24, 201810-K/A	10-K/A	Annual report, amended	Dec 31, 2017
Feb 27, 201810-K	10-K	Annual report, FY2017 — revenue $1.62B (+9% y/y), net income $487.8M, EPS $7.96	Dec 31, 2017

10 current reports (8-K) not listed; the year is on EDGAR.

2017 · 21 filings — 12 × 8-K, 3 × 10-Q, 2 × DEFA14A and 4 other forms

Filed	Form	What it is	Period
Nov 7, 201710-Q	10-Q	Quarterly report, Q3 2017 — revenue $411.9M (+10% y/y), net income $63.5M, EPS $1.03	Sep 30, 2017
Aug 8, 201710-Q	10-Q	Quarterly report, Q2 2017 — revenue $394.4M (+3% y/y), net income $105.6M, EPS $1.72	Jun 30, 2017
Jun 20, 2017DEFA14A	DEFA14A	Additional proxy materials	—
Jun 20, 2017DEFA14A	DEFA14A	Additional proxy materials	—
Jun 20, 2017DEF 14A	DEF 14A	Proxy statement	Aug 3, 2017
Jun 5, 2017PRE 14A	PRE 14A	Preliminary proxy statement	Aug 3, 2017
May 9, 201710-Q	10-Q	Quarterly report, Q1 2017 — revenue $376.1M (+12% y/y), net income $86.5M, EPS $1.41	Mar 31, 2017
Apr 25, 201710-K/A	10-K/A	Annual report, amended	Dec 31, 2016
Feb 28, 201710-K	10-K	Annual report, FY2016 — revenue $1.49B (+12% y/y), net income $396.8M, EPS $6.41	Dec 31, 2016

12 current reports (8-K) not listed; the year is on EDGAR.

2016 · 22 filings — 8 × 8-K, 5 × DEFA14A, 3 × 10-Q and 5 other forms

Counted, not listed; the year is on EDGAR.

2015 · 20 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms

Counted, not listed; the year is on EDGAR.

2014 · 25 filings — 16 × 8-K, 3 × 10-Q, 1 × 10-K and 5 other forms

Counted, not listed; the year is on EDGAR.

2013 · 21 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K and 5 other forms

Counted, not listed; the year is on EDGAR.

2012 · 35 filings — 27 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms

Counted, not listed; the year is on EDGAR.

2011 · 23 filings — 15 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms

Counted, not listed; the year is on EDGAR.

2010 · 23 filings — 16 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms

Counted, not listed; the year is on EDGAR.

2009 · 26 filings — 15 × 8-K, 3 × 10-Q, 2 × 10-K/A and 6 other forms

Counted, not listed; the year is on EDGAR.

2008 · 24 filings — 18 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms

Counted, not listed; the year is on EDGAR.

2007 · 7 filings — 5 × 8-K, 2 × 10-Q

Counted, not listed; the year is on EDGAR.

Insider, ownership and other filings#

Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.

2026 · 112 filings — 71 × 4, 38 × 144, 2 × SCHEDULE 13G and 1 other form

Filed	Form	What it is	Period
Oct 1, 2026144	144	Notice of proposed sale (Form 144)	—
Sep 14, 20264	4	Insider transaction (Form 4)	Sep 10, 2026
Sep 10, 20264	4	Insider transaction (Form 4)	Sep 8, 2026
Sep 10, 20264	4	Insider transaction (Form 4)	Sep 8, 2026
Sep 10, 2026144	144	Notice of proposed sale (Form 144)	—
Sep 8, 2026144	144	Notice of proposed sale (Form 144)	—
Sep 8, 2026144	144	Notice of proposed sale (Form 144)	—
Sep 2, 20264	4	Insider transaction (Form 4)	Aug 31, 2026
Sep 2, 20264	4	Insider transaction (Form 4)	Aug 31, 2026
Sep 2, 20264	4	Insider transaction (Form 4)	Aug 31, 2026
Sep 2, 20264	4	Insider transaction (Form 4)	Aug 31, 2026
Sep 2, 20264	4	Insider transaction (Form 4)	Aug 31, 2026
Sep 2, 20264	4	Insider transaction (Form 4)	Aug 31, 2026
Sep 2, 20264	4	Insider transaction (Form 4)	Aug 31, 2026
Sep 2, 20264	4	Insider transaction (Form 4)	Aug 31, 2026
Sep 2, 20264	4	Insider transaction (Form 4)	Aug 31, 2026
Sep 2, 20264	4	Insider transaction (Form 4)	Aug 31, 2026
Sep 2, 20264	4	Insider transaction (Form 4)	Aug 31, 2026
Sep 1, 2026144	144	Notice of proposed sale (Form 144)	—
Aug 31, 20264	4	Insider transaction (Form 4)	Aug 27, 2026
Aug 31, 2026144	144	Notice of proposed sale (Form 144)	—
Aug 31, 2026144	144	Notice of proposed sale (Form 144)	—
Aug 31, 2026144	144	Notice of proposed sale (Form 144)	—
Aug 31, 2026144	144	Notice of proposed sale (Form 144)	—
Aug 31, 2026144	144	Notice of proposed sale (Form 144)	—

The newest 25 of 112 shown; the full year is on EDGAR.

2025 · 115 filings — 58 × 4, 38 × 144, 9 × SC TO-T/A and 5 other forms

Filed	Form	What it is	Period
Dec 11, 20254	4	Insider transaction (Form 4)	Dec 9, 2025
Dec 10, 20253	3	Initial insider holdings (Form 3)	Dec 1, 2025
Dec 9, 2025144	144	Notice of proposed sale (Form 144)	—
Dec 9, 20254	4	Insider transaction (Form 4)	Dec 5, 2025
Dec 9, 20254	4	Insider transaction (Form 4)	Dec 5, 2025
Dec 5, 2025144	144	Notice of proposed sale (Form 144)	—
Dec 4, 20254	4	Insider transaction (Form 4)	Dec 2, 2025
Dec 1, 2025144	144	Notice of proposed sale (Form 144)	—
Dec 1, 20254	4	Insider transaction (Form 4)	Nov 26, 2025
Nov 26, 2025144	144	Notice of proposed sale (Form 144)	—
Nov 24, 20254	4	Insider transaction (Form 4)	Nov 20, 2025
Nov 21, 20254	4	Insider transaction (Form 4)	Nov 19, 2025
Nov 20, 20254	4	Insider transaction (Form 4)	Nov 18, 2025
Nov 20, 20254	4	Insider transaction (Form 4)	Nov 18, 2025
Nov 20, 20254	4	Insider transaction (Form 4)	Nov 18, 2025
Nov 20, 2025144	144	Notice of proposed sale (Form 144)	—
Nov 19, 2025144	144	Notice of proposed sale (Form 144)	—
Nov 19, 20254	4	Insider transaction (Form 4)	Nov 17, 2025
Nov 18, 2025144	144	Notice of proposed sale (Form 144)	—
Nov 18, 2025144	144	Notice of proposed sale (Form 144)	—
Nov 18, 2025144	144	Notice of proposed sale (Form 144)	—
Nov 17, 2025144	144	Notice of proposed sale (Form 144)	—
Oct 3, 20254	4	Insider transaction (Form 4)	Oct 1, 2025
Oct 3, 2025144	144	Notice of proposed sale (Form 144)	—
Sep 17, 20254	4	Insider transaction (Form 4)	Sep 14, 2025

The newest 25 of 115 shown; the full year is on EDGAR.

2024 · 67 filings — 42 × 4, 17 × 144, 4 × SC 13G/A and 2 other forms

Filed	Form	What it is	Period
Dec 9, 20244	4	Insider transaction (Form 4)	Dec 5, 2024
Dec 4, 20244	4	Insider transaction (Form 4)	Dec 2, 2024
Dec 4, 20244	4	Insider transaction (Form 4)	Dec 2, 2024
Dec 2, 2024144	144	Notice of proposed sale (Form 144)	—
Dec 2, 2024144	144	Notice of proposed sale (Form 144)	—
Nov 13, 20244	4	Insider transaction (Form 4)	Nov 8, 2024
Nov 12, 2024SC 13G/A	SC 13G/A	Passive holder above 5% (Schedule 13G), amended	—
Nov 8, 2024144	144	Notice of proposed sale (Form 144)	—
Nov 5, 20244	4	Insider transaction (Form 4)	Nov 1, 2024
Nov 1, 2024144	144	Notice of proposed sale (Form 144)	—
Oct 21, 2024SC 13G/A	SC 13G/A	Passive holder above 5% (Schedule 13G), amended	—
Sep 11, 20244	4	Insider transaction (Form 4)	Sep 6, 2024
Sep 5, 2024144	144	Notice of proposed sale (Form 144)	—
Aug 6, 20244	4	Insider transaction (Form 4)	Aug 2, 2024
Aug 6, 20244	4	Insider transaction (Form 4)	Aug 2, 2024
Aug 6, 20244	4	Insider transaction (Form 4)	Aug 2, 2024
Aug 6, 20244	4	Insider transaction (Form 4)	Aug 2, 2024
Aug 6, 20244	4	Insider transaction (Form 4)	Aug 2, 2024
Aug 6, 20244	4	Insider transaction (Form 4)	Aug 2, 2024
Aug 6, 20244	4	Insider transaction (Form 4)	Aug 2, 2024
Aug 6, 20244	4	Insider transaction (Form 4)	Aug 2, 2024
Aug 6, 20244	4	Insider transaction (Form 4)	Aug 2, 2024
Aug 6, 20244	4	Insider transaction (Form 4)	Aug 2, 2024
Aug 6, 20244	4	Insider transaction (Form 4)	Aug 2, 2024
Aug 6, 20244	4	Insider transaction (Form 4)	Aug 2, 2024

The newest 25 of 67 shown; the full year is on EDGAR.

2023 · 68 filings — 44 × 4, 17 × 144, 4 × SC 13G/A and 3 other forms

Counted, not listed; the year is on EDGAR.

2022 · 74 filings — 67 × 4, 4 × SC 13G/A, 1 × 5 and 2 other forms

Counted, not listed; the year is on EDGAR.

2021 · 70 filings — 63 × 4, 3 × SC 13G/A, 2 × S-8 and 2 other forms

Counted, not listed; the year is on EDGAR.

2020 · 76 filings — 56 × 4, 5 × 3, 4 × CT ORDER and 6 other forms

Counted, not listed; the year is on EDGAR.

2019 · 60 filings — 44 × 4, 5 × 3, 4 × SC 13G/A and 6 other forms

Counted, not listed; the year is on EDGAR.

2018 · 88 filings — 76 × 4, 4 × SC 13G/A, 3 × CT ORDER and 4 other forms

Counted, not listed; the year is on EDGAR.

2017 · 74 filings — 65 × 4, 4 × SC 13G/A, 2 × CT ORDER and 3 other forms

Counted, not listed; the year is on EDGAR.

2016 · 97 filings — 78 × 4, 4 × SC TO-T/A, 3 × SC 13G/A and 8 other forms

Counted, not listed; the year is on EDGAR.

2015 · 97 filings — 84 × 4, 3 × CORRESP, 3 × CT ORDER and 6 other forms

Counted, not listed; the year is on EDGAR.

2014 · 124 filings — 90 × 4, 11 × SC TO-T/A, 5 × 3 and 11 other forms

Counted, not listed; the year is on EDGAR.

2013 · 88 filings — 65 × 4, 5 × CORRESP, 4 × UPLOAD and 10 other forms

Counted, not listed; the year is on EDGAR.

2012 · 133 filings — 75 × 4, 18 × 3, 6 × S-8 POS and 17 other forms

Counted, not listed; the year is on EDGAR.

2011 · 75 filings — 42 × 4, 19 × 425, 5 × 3 and 5 other forms

Counted, not listed; the year is on EDGAR.

2010 · 62 filings — 39 × 4, 4 × EFFECT, 4 × POS AM and 8 other forms

Counted, not listed; the year is on EDGAR.

2009 · 64 filings — 28 × 4, 6 × SC 13G/A, 3 × 3 and 14 other forms

Counted, not listed; the year is on EDGAR.

2008 · 79 filings — 47 × 4, 7 × 4/A, 7 × SC 13G and 9 other forms

Counted, not listed; the year is on EDGAR.

2007 · 65 filings — 31 × 4, 16 × 3, 5 × S-1/A and 10 other forms

Counted, not listed; the year is on EDGAR.

2006 · 2 filings — 2 × REGDEX/A

Counted, not listed; the year is on EDGAR.

2005 · 2 filings — 1 × REGDEX, 1 × SC 13D

Counted, not listed; the year is on EDGAR.

2004 · 3 filings — 2 × REGDEX/A, 1 × REGDEX

Counted, not listed; the year is on EDGAR.

2003 · 2 filings — 1 × REGDEX, 1 × REGDEX/A

Counted, not listed; the year is on EDGAR.

About this data

Jazz Pharmaceuticals plc Common Stock (Ireland) (JAZZ) has 2,164 filings on EDGAR going back to 2003: 37 annual reports, 59 quarterly reports and 275 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 24, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Sep 23, 2026, covered material definitive agreement; new financial obligation. Over the last 13 months insiders sold $46.0M in 22 sales and bought nothing on the open market; 74 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.

Every row is a filing EDGAR lists for the registrants that have been Jazz Pharmaceuticals plc Common Stock (Ireland), read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.

FAQ#

Where can I read JAZZ's latest 10-K?: JAZZ's latest annual report, a 10-K, was filed on Feb 24, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
When did JAZZ last file an 8-K?: On Sep 23, 2026: material definitive agreement; new financial obligation. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Aug 3, 2026.
Are JAZZ insiders buying or selling?: Over the last 13 months insiders sold $46.0M in 22 sales and bought nothing on the open market; 74 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: Patil Neena M (EVP & Chief Legal Officer) sold 1,200 shares on Sep 10, 2026 for $289K, under a 10b5-1 plan. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
How many SEC filings has JAZZ made?: 2,164 filings are on EDGAR under the registrant records that have been Jazz Pharmaceuticals plc Common Stock (Ireland), going back to 2003; 1,371 of them are insider ownership forms (Forms 3, 4, 5 and 144).

JAZZ SEC filings (2026)

What happened, last 12 months#

September 2026

August 2026

July 2026

June 2026

May 2026

April 2026

March 2026

February 2026

January 2026

November 2025

October 2025

Insider transactions#

Reports and proxy statements#

Insider, ownership and other filings#

About this data

FAQ#